Cephalalgia最新文献

筛选
英文 中文
Headache in Sturge-Weber syndrome: A systematic review. 斯特格-韦伯综合征的头痛:系统综述。
IF 5 2区 医学
Cephalalgia Pub Date : 2024-07-01 DOI: 10.1177/03331024241265881
Alessandro Ferretti, Marta Muscianese, Claudia Fanfoni, Giulia Bellone, Maurizio Mennini, Giovanni Di Nardo, Solmaz Abdolrahimzadeh, Gabriella De Marco, Alessandro Orsini, Thomas Foiadelli, Ilaria Frattale, Massimiliano Valeriani, Pasquale Parisi
{"title":"Headache in Sturge-Weber syndrome: A systematic review.","authors":"Alessandro Ferretti, Marta Muscianese, Claudia Fanfoni, Giulia Bellone, Maurizio Mennini, Giovanni Di Nardo, Solmaz Abdolrahimzadeh, Gabriella De Marco, Alessandro Orsini, Thomas Foiadelli, Ilaria Frattale, Massimiliano Valeriani, Pasquale Parisi","doi":"10.1177/03331024241265881","DOIUrl":"10.1177/03331024241265881","url":null,"abstract":"<p><strong>Background: </strong>Sturge-Weber syndrome (SWS) is a neurocutaneous disorder for which the neurological aspects, particularly headaches, remain poorly understood, despite significantly affecting morbidity. The present study aimed to elucidate the prevalence, characteristics and treatment strategies, as well as explore the pathogenesis of headaches, in SWS.</p><p><strong>Methods: </strong>Using Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, we systematically reviewed observational studies, case reports and series from eight databases (Cochrane Library, EBSCO, Embase, Medline, PubMed, Science Direct, Scopus and Web of Science), published from 1978 to 2023, to investigate the prevalence, characteristics, medication response and pathogenic theories of headaches in SWS.</p><p><strong>Results: </strong>The review analyzed 48 studies, uncovering headache prevalence between 37% and 71%. Migraine-like headache affected up to 52% of individuals. Prophylactic and acute treatments included non-steroidal anti-inflammatory drugs, triptans and antiepileptic drugs, despite the lack of established guidelines. Life-threatening headaches in SWS are uncommon, typically accompanied by other neurological symptoms. The pathogenesis of headaches in SWS is considered to involve venous congestion and neuronal hyperexcitability linked to leptomeningeal angiomas.</p><p><strong>Conclusions: </strong>Headaches occur more frequently in individuals with SWS than in the general population. Despite symptoms meeting migraine criteria, these headaches should be considered secondary to vascular conditions. Implementing acute and prophylactic treatment is advised to reduce the impact on patients' lives.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 7","pages":"3331024241265881"},"PeriodicalIF":5.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding. 成年无先兆偏头痛患者的视听联想对学习能力增强:意想不到的发现
IF 5 2区 医学
Cephalalgia Pub Date : 2024-07-01 DOI: 10.1177/03331024241258722
Kálmán Tót, Gábor Braunitzer, Noémi Harcsa-Pintér, Ádám Kiss, Balázs Bodosi, János Tajti, Anett Csáti, Gabriella Eördegh, Attila Nagy
{"title":"Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding.","authors":"Kálmán Tót, Gábor Braunitzer, Noémi Harcsa-Pintér, Ádám Kiss, Balázs Bodosi, János Tajti, Anett Csáti, Gabriella Eördegh, Attila Nagy","doi":"10.1177/03331024241258722","DOIUrl":"https://doi.org/10.1177/03331024241258722","url":null,"abstract":"<p><strong>Background: </strong>Altered sensory processing in migraine has been demonstrated by several studies in unimodal, and especially visual, tasks. While there is some limited evidence hinting at potential alterations in multisensory processing among migraine sufferers, this aspect remains relatively unexplored. This study investigated the interictal cognitive performance of migraine patients without aura compared to matched controls, focusing on associative learning, recall, and transfer abilities through the Sound-Face Test, an audiovisual test based on the principles of the Rutgers Acquired Equivalence Test.</p><p><strong>Materials and methods: </strong>The performance of 42 volunteering migraine patients was compared to the data of 42 matched controls, selected from a database of healthy volunteers who had taken the test earlier. The study aimed to compare the groups' performance in learning, recall, and the ability to transfer learned associations.</p><p><strong>Results: </strong>Migraine patients demonstrated significantly superior associative learning as compared to controls, requiring fewer trials, and making fewer errors during the acquisition phase. However, no significant differences were observed in retrieval error ratios, generalization error ratios, or reaction times between migraine patients and controls in later stages of the test.</p><p><strong>Conclusion: </strong>The results of our study support those of previous investigations, which concluded that multisensory processing exhibits a unique pattern in migraine. The specific finding that associative audiovisual pair learning is more effective in adult migraine patients than in matched controls is unexpected. If the phenomenon is not an artifact, it may be assumed to be a combined result of the hypersensitivity present in migraine and the sensory threshold-lowering effect of multisensory integration.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 7","pages":"3331024241258722"},"PeriodicalIF":5.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141878455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. 更正:基于患者性别的降钙素基因相关肽(CGRP)靶向疗法对急性和预防性偏头痛治疗效果的评估。
IF 5 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241254952
{"title":"Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.","authors":"","doi":"10.1177/03331024241254952","DOIUrl":"https://doi.org/10.1177/03331024241254952","url":null,"abstract":"","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241254952"},"PeriodicalIF":5.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab. 对 CGRP 的超敏反应是使用艾伦单抗预防偏头痛的预测性生物标志物。
IF 5 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241258734
Haidar M Al-Khazali, Håkan Ashina, Rune Häckert Christensen, Astrid Wiggers, Kathrine Rose, Afrim Iljazi, Faisal Mohammad Amin, Messoud Ashina, Josefin Snellman, Tina Maio-Twofoot, Henrik W Schytz
{"title":"Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.","authors":"Haidar M Al-Khazali, Håkan Ashina, Rune Häckert Christensen, Astrid Wiggers, Kathrine Rose, Afrim Iljazi, Faisal Mohammad Amin, Messoud Ashina, Josefin Snellman, Tina Maio-Twofoot, Henrik W Schytz","doi":"10.1177/03331024241258734","DOIUrl":"10.1177/03331024241258734","url":null,"abstract":"<p><strong>Background: </strong>The present study aimed to investigate the predictive value of calcitonin gene-related peptide (CGRP)-induced migraine attacks for effectiveness to erenumab treatment in people with migraine.</p><p><strong>Methods: </strong>In total, 139 participants with migraine underwent a single experimental day involving a 20-min infusion with CGRP. Following this, the participants entered a 24-week treatment period with erenumab. The primary endpoints were the predictive value of CGRP-induced migraine attacks on the effectiveness of erenumab, defined as ≥50% reduction in monthly migraine days, or ≥ 50% reduction in either monthly migraine or monthly headache days of moderate to severe intensity.</p><p><strong>Results: </strong>Among participants with CGRP-induced migraine attacks, 60 of 99 (61%) achieved ≥50% reduction in monthly migraine days during weeks 13-24 with erenumab. Conversely, 13 of 25 (52%) where CGRP infusion did not induce a migraine achieved the same endpoint (<i>p</i> = 0.498). There were no significant differences between the ≥50% reduction in either monthly migraine or monthly headache days of moderate to severe intensity between CGRP-sensitive and non-sensitive participants (<i>p</i> = 0.625).</p><p><strong>Conclusions: </strong>Our findings suggest that the CGRP-provocation model cannot be used to predict erenumab's effectiveness. It remains uncertain whether this finding extends to other monoclonal antibodies targeting the CGRP ligand or to gepants.<b>Trial Registration:</b> The study was registered at ClinicalTrials.gov (NCT04592952).</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241258734"},"PeriodicalIF":5.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REPLY to Comment on Correlation between endometriosis and migraine features: Results from a prospective case-control study'': Correlation between endometriosis and migraine features is not based on a broad strokes results. REPLY to Comment on Correlation between endometriosis and migraine features:一项前瞻性病例对照研究的结果'':子宫内膜异位症与偏头痛特征之间的相关性并非基于一刀切的结果。
IF 4.9 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241254821
Caterina Exacoustos, Francesco Giuseppe Martire, Maria Albanese, Aikaterini Selntigia
{"title":"REPLY to Comment on Correlation between endometriosis and migraine features: Results from a prospective case-control study'': Correlation between endometriosis and migraine features is not based on a broad strokes results.","authors":"Caterina Exacoustos, Francesco Giuseppe Martire, Maria Albanese, Aikaterini Selntigia","doi":"10.1177/03331024241254821","DOIUrl":"https://doi.org/10.1177/03331024241254821","url":null,"abstract":"","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241254821"},"PeriodicalIF":4.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Registry-based safety studies of migraine drugs in pregnancy: Acknowledging our failures. 以登记为基础的妊娠期偏头痛药物安全性研究:承认我们的失败
IF 4.9 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241262486
Alain Braillon
{"title":"Registry-based safety studies of migraine drugs in pregnancy: Acknowledging our failures.","authors":"Alain Braillon","doi":"10.1177/03331024241262486","DOIUrl":"https://doi.org/10.1177/03331024241262486","url":null,"abstract":"","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241262486"},"PeriodicalIF":4.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual snow syndrome or "what's in a name?" 视觉雪综合症或 "名字里有什么"?
IF 4.9 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241259359
Gordon T Plant
{"title":"Visual snow syndrome or \"what's in a name?\"","authors":"Gordon T Plant","doi":"10.1177/03331024241259359","DOIUrl":"10.1177/03331024241259359","url":null,"abstract":"","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241259359"},"PeriodicalIF":4.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141287853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Onabotulinumtoxina (craniotomy scar combined with cranial suture line injections) for persistent post craniotomy headache: Case series with long-term follow-up. Onabotulinumtoxina (开颅手术疤痕联合头颅缝合线注射)治疗开颅手术后顽固性头痛:长期随访的病例系列。
IF 5 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241259452
Janet Leon, Todd D Rozen, Alok A Bhatt
{"title":"Onabotulinumtoxina (craniotomy scar combined with cranial suture line injections) for persistent post craniotomy headache: Case series with long-term follow-up.","authors":"Janet Leon, Todd D Rozen, Alok A Bhatt","doi":"10.1177/03331024241259452","DOIUrl":"10.1177/03331024241259452","url":null,"abstract":"<p><strong>Background: </strong>There is no defined preventive treatment protocol for persistent post-craniotomy headache. In several small case series and individual case reports onabotulinumtoxinA injected into the craniotomy scar has shown possible efficacy. What is lacking is long term follow-up and if focusing on the cranial suture lines along with the craniotomy scar can enhance improvement and provide more sustained benefit.</p><p><strong>Methods: </strong>Retrospective chart review with case series.</p><p><strong>Results: </strong>Four patients (three women, one man) with ICHD-3 defined persistent post craniotomy headache were treated using a novel onabotulinumtoxinA injection protocol. All the patients presented with continuous head pain of moderate to severe intensity. All had severe allodynia on the side of their craniotomy. All had significant reduction in quality of life. Our application of onabotulinumtoxinA involved injection into both the surgical scar and the transected/irritated cranial suture lines noted on neuroimaging and physical examination. With treatment all patients demonstrated significant benefit including a reduction in daily pain intensity (75%-100%), developing periods of pain freedom (2-7 days per week) and having a dramatic improvement in quality of life (close to 100% in all). The benefit was sustained for at least five years of follow-up.</p><p><strong>Conclusion: </strong>From our case series it appears that injection not only along the painful craniotomy scar but into the involved cranial suture lines provides positive efficacy and sustained improvement in patients with persistent post craniotomy headache.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241259452"},"PeriodicalIF":5.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141316856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials". 评估 CGRP mAbs 和 gepants 预防治疗偏头痛的疗效:第 3 期随机对照试验的系统综述和网络荟萃分析 "的更正。
IF 5 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241255216
{"title":"Corrigendum to \"Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials\".","authors":"","doi":"10.1177/03331024241255216","DOIUrl":"https://doi.org/10.1177/03331024241255216","url":null,"abstract":"","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241255216"},"PeriodicalIF":5.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latent class analysis of migraine associated vestibular-auditory symptoms. 偏头痛相关前庭-听觉症状的潜类分析。
IF 4.9 2区 医学
Cephalalgia Pub Date : 2024-06-01 DOI: 10.1177/03331024241262488
Hui Li, Xiaonuo Xu, Rongjiang Xu, Ping Xiao Fan, Jiying Zhou, Liang Dong
{"title":"Latent class analysis of migraine associated vestibular-auditory symptoms.","authors":"Hui Li, Xiaonuo Xu, Rongjiang Xu, Ping Xiao Fan, Jiying Zhou, Liang Dong","doi":"10.1177/03331024241262488","DOIUrl":"https://doi.org/10.1177/03331024241262488","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify the potential subgroups of migraines based on the patterns of migraine associated symptoms, vestibular and auditory symptoms using latent class analysis and to explore their characteristics.</p><p><strong>Method: </strong>A total of 555 patients with migraine participated in the study. Symptoms such as nausea, vomiting, photophobia, phonophobia, osmophobia, visual symptoms, vestibular symptoms (dizziness, vertigo), and auditory symptoms (tinnitus, hearing loss, aural fullness) were assessed. Latent class analysis was performed to identify subgroups of migraines. Covariates such as gender, age of migraine onset, frequency of migraine attacks per month, and family history were also considered.</p><p><strong>Results: </strong>The analysis revealed four latent classes: the Prominent Vestibular; Prominent Nausea; Presenting Symptoms but not prominent or dominant; and Sensory Hypersensitivity groups. Various covariates, such as gender, age of migraine onset, and frequency of migraine attacks, demonstrated significant differences among the four groups. The Sensory Hypersensitivity group showed the presence of multiple sensory symptoms, earlier age of migraine onset, and higher proportion of females. The Prominent Vestibular group had the highest probability of dizziness or vertigo but lacked the presence of auditory symptoms. The Prominent Nausea group exhibited prominent nausea. The Presenting Symptoms but not prominent or dominant group comprised individuals with the highest migraine attacks per month and proportion of chronic migraine.</p><p><strong>Conclusion: </strong>This study identifies four subgroups of migraines based on the patterns of symptoms. The findings suggest potential different but overlapped mechanisms behind the vestibular and auditory symptoms of migraine. Considering the different patterns of migraine-related symptoms may provide deeper insights for patients' prognosis and clinical decision-making.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"44 6","pages":"3331024241262488"},"PeriodicalIF":4.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141418120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信